학술논문

Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial
Document Type
Article
Source
In Blood Advances 14 November 2023 7(21):6441-6450
Subject
Myeloid Neoplasia
Clinical Trials and Observations
Language
ISSN
2473-9529